Equipment and Accessories for Modern High-Effective Technology of Ozone Therapy and Ozone prophylaxis
Equipment and Accessories for Modern High-Effective Technology of Ozone Therapy and Ozone prophylaxis
This website uses cookies to ensure
you get the best experience.
you get the best experience.
Leave feedback
The information which you give in completing this form will be forwarded to the designated party for its use and will not be provided by us to any other parties.
Follow-up to the preliminary results about the systemic use of O2/O3 in the treatment of COVID-19
Follow-up to the preliminary results about use of sistemic of O2/O3 in the treatment of Novel Coronavirus Pneumonia (COVID-19).
Date and Version No:6 — 18/04/2020
Download the original document
Date and Version No:6 — 18/04/2020
Download the original document
Security alert: MAH volume > 100 mL // Risk of thrombus in COVID-19 + Patients Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated with coagulopathy namely disseminated intravascular coagulation. If your protocol includes MAH use blood volume < 100 mL, use d-dimer as biomarker of potential coagulopathy.